The rising demand reported in therapeutics segment is prognosticated to catapult it to the fore of the Global Antithrombin Market in terms of application, finds Fortune Business Insights in a new study. The study is titled “Antithrombin Market: Global Market Analysis, Insights, and Forecasts, 2018 2026.” According to the study, the global antithrombin market will exhibit a steady CAGR of 4.1% to reach a value of US$ 725.2 Mn by 2026 from US$ 490.4 Mn in 2018.
Browse Complete Report Details https://www.fortunebusinessinsights.com/industry-reports/antithrombin-market-100470
Strong Distribution Network Enables SCL Behring, Grifols, and Shire Expand Global Footprint
The global antithrombin market was dominated by three major companies namely SCL Behring, Grifols, and Shire. In 2018, these three companies together accounted for the highest market share among others. They offer the most commonly used human antithrombin based anticoagulants. Besides this, they have a strong distribution network that makes them have the lion’s share.
Asia Pacific Market to Exhibit Fastest Growth, Gaining Momentum from Rising Disposable Incomes
Geographically, the global antithrombin market is anticipated to show the fastest growth in Asia Pacific. In 2018, the antithrombin market was valued at US$ 179.7 Mn from Asia Pacific alone. A major reason behind this growth is the fact that developing nations such as India and China are adopting new treatment procedures and techniques to fight back various diseases. The rise in disposable incomes of people in developing nations and their increasing ability to spend more on advanced healthcare and medical aid will create lucrative growth opportunities for the market in Asia Pacific.
Again, Europe is expected to showcase huge potential for growth for antithrombin market during the forecast period. This is because countries such as the UK, Germany, France, and others are adopting human antithrombin based products on a large scale.
Get PDF Brochure of this Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/antithrombin-market-100470
Segmentation
By Application
By Source
By Dosage Form
Increasing Prevalence of Hereditary Antithrombin Deficiency to Boost Market
The rising prevalence of medical conditions such as sepsis, hereditary antithrombin deficiency,disseminated intravascular coagulation (DIC), and extracorporeal membrane oxygenation (ECMO) is creating lucrative growth opportunities for the antithrombin market. Among various application types, the therapeutics segment is anticipated to lead the market with rising number of antithrombin deficiency cases. In 2018, the therapeutics segment accounted for about 95.7% of the market and is likely to continue its dominance in the future as Fortune Business Insights.
However, the high treatment cost of antithrombin may compel end users to look for cheaper alternatives or supplements. This may hamper the market globally. Again, developing countries in Asia Pacific may directly opt out of adopting antithrombin treatment because of the high price of this treatment. This may pose a challenge for market players, also hampering the overall profit percentage of the market.
More Trending Topics From Fortune Business Insights@
Potential Opportunities of Peritoneal Dialysis Market | Size Share Growth 2025
Immunodiagnostics Market Set for Rapid Growth | Trend and Demands 2026
Press Release Distributed by The Express Wire
To view the original version on The Express Wire visit Antithrombin Market to Exhibit 4.1% CAGR, Rising Prevalence of Hereditary Antithrombin Deficiency to Boost Market